prader willi syndrome glp 1 Updates on Obesity in Prader-Willi Syndrome: From Genetics to Management New commentary offers practical guidance

That isnt to say you cant (or shouldnt) stop taking these medications if your side effects are severe

4 A history of gallbladder disease A 2022 systematic review of 76 randomised trials found that GLP-1 medications are associated with a relative risk of around 37% for gallbladder or biliary disease, with a higher relative risk in weight-loss trials than in diabetes trials

In another study, people taking Contrave lost an average of 510% of their body weight over 12 months when the medicine was combined with a healthy diet and regular exercise

& Heagerty, A

Exenatide must be injected subcutaneously (abdomen, thigh, or upper arm) twice daily prior to eating meals